loader
Please Wait
Applying Filters...

List of All Manufacturers & Suppliers of Leuprolide Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Menu
$ API Ref.Price (USD/KG) : 128,417Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Sanofi

02 43AbbVie Inc

03 16Orion Corporation

04 6Pharmathen SA

05 5Omgene Life Sciences Pvt. Ltd

06 42care4 ApS

07 4Accure Labs

08 1Amneal Pharmaceuticals

09 9Astellas Pharma

10 1Aurobindo Pharma Limited

11 6Biological E

12 3Cross Pharma AB

13 4Eriochem S.A.

14 2Eurolab

15 4GP Pharm

16 4Health Biotech

17 1InvaGen Pharmaceuticals Inc

18 1Jodas Expoim Pvt. Ltd

19 3Key Oncologics

20 1McNeil Consumer Health

21 3Medartuum AB

22 1Meitheal Pharmaceuticals

23 5Mundipharma

24 4ORIFARM GROUP AS

25 2Omnia Pharmaceutical AB

26 1Paranova Läkemedel AB

27 4Pharmachim AB

28 2Pluviaendo

29 1RK Pharma

30 3Recordati

31 11Sandoz B2B

32 1Savior Lifetec Corporation

33 1Sun Pharmaceutical Industries Limited

34 4TOLMAR INTERNATIONAL LTD.

35 3Takeda Pharmaceutical

36 2TherDose Pharma

37 5Tolmar

38 2VERITY PHARMACEUTICALS INC.

39 2Varian Pharmed

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Regulatory Info :

Registration Country : India

Leuprolide Acetate

Brand Name :

Dosage Form : Depot Injection

Dosage Strength : 3.75MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Omgene Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Regulatory Info : DISCN

Registration Country : USA

LEUPROLIDE ACETATE

Brand Name : LEUPROLIDE ACETATE

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 14MG/2.8ML (1MG/0.2ML)

Packaging :

Approval Date : 2001-11-29

Application Number : 75721

Regulatory Info : DISCN

Registration Country : USA

Sanofi Company Banner

03

arrow
Discovery on Target
Not Confirmed

LEUPROLIDE ACETATE

Brand Name : LUPRON

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : 14MG/2.8ML (1MG/0.2ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1985-04-09

Application Number : 19010

Regulatory Info : DISCN

Registration Country : USA

Abbvie Company Banner

04

arrow
Discovery on Target
Not Confirmed

leuprorelinacetat

Brand Name : Enanton Depot Dual

Dosage Form : PULVER OCH VÄTSKA TILL INJEKTIONSVÄTSKA

Dosage Strength : 30 MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

Fermion Orion Company Banner

05

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothPharmathen provides life cycle Management solutions for branded pharma, as well as to develop & establish new technology platforms.

Regulatory Info : USA

Registration Country : Greece

Leuprolide Acetate

Brand Name :

Dosage Form : Long Acting Injectable

Dosage Strength : 3.75MG

Packaging :

Approval Date :

Application Number :

Regulatory Info : USA

Registration Country : Greece

Pharmathen

06

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Regulatory Info :

Registration Country : India

Leuprolide Acetate

Brand Name :

Dosage Form : Depot Injection

Dosage Strength : 7.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Omgene Company Banner

07

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Regulatory Info :

Registration Country : India

Leuprolide Acetate

Brand Name :

Dosage Form : Depot Injection

Dosage Strength : 22.5MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Omgene Company Banner

08

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Regulatory Info :

Registration Country : India

Leuprolide Acetate

Brand Name :

Dosage Form : Depot Injection

Dosage Strength : 30MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Omgene Company Banner

09

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothOmgene: R&D-based biopharmaceutical company with GMP facilities, focused on innovation and high-quality, affordable medicines.

Regulatory Info :

Registration Country : India

Leuprolide Acetate

Brand Name :

Dosage Form : Depot Injection

Dosage Strength : 45MG

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : India

Omgene Company Banner

10

arrow
Discovery on Target
Not Confirmed

LEUPROLIDE ACETATE

Brand Name : LUPRON DEPOT

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 7.5MG

Packaging :

Approval Date : 1989-01-26

Application Number : 19732

Regulatory Info : RX

Registration Country : USA

Abbvie Company Banner

11

arrow
Discovery on Target
Not Confirmed

LEUPROLIDE ACETATE

Brand Name : LUPRON DEPOT

Dosage Form : INJECTABLE; INJECTION

Dosage Strength : 3.75MG

Packaging :

Approval Date :

Application Number : 19943

Regulatory Info :

Registration Country : USA

Abbvie Company Banner

12

arrow
Discovery on Target
Not Confirmed

LEUPROLIDE ACETATE

Brand Name : LUPRON DEPOT

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 3.75MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1990-10-22

Application Number : 20011

Regulatory Info : DISCN

Registration Country : USA

Abbvie Company Banner

13

arrow
Discovery on Target
Not Confirmed

LEUPROLIDE ACETATE

Brand Name : LUPRON DEPOT

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 3.75MG

Packaging :

Approval Date : 1995-10-26

Application Number : 20011

Regulatory Info : RX

Registration Country : USA

Abbvie Company Banner

14

arrow
Discovery on Target
Not Confirmed

LEUPROLIDE ACETATE

Brand Name : LUPRON DEPOT-PED KIT

Dosage Form : POWDER;INTRAMUSCULAR

Dosage Strength : 7.5MG

Packaging :

Approval Date : 1993-04-16

Application Number : 20263

Regulatory Info : RX

Registration Country : USA

Abbvie Company Banner

15

arrow
Discovery on Target
Not Confirmed

LEUPROLIDE ACETATE

Brand Name : LUPRON DEPOT-PED KIT

Dosage Form : POWDER;INTRAMUSCULAR

Dosage Strength : 3.75MG,7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1993-04-16

Application Number : 20263

Regulatory Info : DISCN

Registration Country : USA

Abbvie Company Banner

16

arrow
Discovery on Target
Not Confirmed

LEUPROLIDE ACETATE

Brand Name : LUPRON DEPOT-PED KIT

Dosage Form : POWDER;INTRAMUSCULAR

Dosage Strength : 7.5MG,7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Packaging :

Approval Date : 1993-04-16

Application Number : 20263

Regulatory Info : DISCN

Registration Country : USA

Abbvie Company Banner

17

arrow
Discovery on Target
Not Confirmed

LEUPROLIDE ACETATE

Brand Name : LUPRON DEPOT-PED KIT

Dosage Form : POWDER;INTRAMUSCULAR

Dosage Strength : 11.25MG

Packaging :

Approval Date : 1994-01-21

Application Number : 20263

Regulatory Info : RX

Registration Country : USA

Abbvie Company Banner

18

arrow
Discovery on Target
Not Confirmed

LEUPROLIDE ACETATE

Brand Name : LUPRON DEPOT-PED KIT

Dosage Form : POWDER;INTRAMUSCULAR

Dosage Strength : 15MG

Packaging :

Approval Date : 1994-01-21

Application Number : 20263

Regulatory Info : RX

Registration Country : USA

Abbvie Company Banner

19

arrow
Discovery on Target
Not Confirmed

LEUPROLIDE ACETATE

Brand Name : LUPRON DEPOT-PED KIT

Dosage Form : POWDER;INTRAMUSCULAR

Dosage Strength : 11.25MG

Packaging :

Approval Date : 2011-08-15

Application Number : 20263

Regulatory Info : RX

Registration Country : USA

Abbvie Company Banner

20

arrow
Discovery on Target
Not Confirmed

LEUPROLIDE ACETATE

Brand Name : LUPRON DEPOT-PED KIT

Dosage Form : POWDER;INTRAMUSCULAR

Dosage Strength : 30MG

Packaging :

Approval Date : 2011-08-15

Application Number : 20263

Regulatory Info : RX

Registration Country : USA

Abbvie Company Banner